대한치매학회

Original Article

2026; 25 91 - 102/dnd-25-91.pdf 전문보기

AI-Based Dementia Prediction From Low-Dose Brain CT in Mild Cognitive Impairments

Seongbeom Park ,¹ Jehyun Ahn ,²,³ Duk L. Na ,²,³ Kichang Kwak ,¹, Jun Pyo Kim ,²,³ On behalf of the K-ROAD study
¹BeauBrain Healthcare, Inc., Seoul, Korea ²Alzheimer’s Disease Convergence Research Center, Samsung Medical Center, Seoul, Korea ³ Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

AI-Based Dementia Prediction From Low-Dose Brain CT in Mild Cognitive Impairments

Seongbeom Park ,¹ Jehyun Ahn ,²,³ Duk L. Na ,²,³ Kichang Kwak ,¹, Jun Pyo Kim ,²,³ On behalf of the K-ROAD study
¹BeauBrain Healthcare, Inc., Seoul, Korea ²Alzheimer’s Disease Convergence Research Center, Samsung Medical Center, Seoul, Korea ³ Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

2026; 25 91 - 102

Mild Cognitive Impairment; Dementia; Artificial Intelligence; Tomography, X-ray Computed; Health Technology Assessment;

Original Article

2026; 25 103 - 114/dnd-25-103.pdf 전문보기

Dysphagia Characteristics and Its Neuroanatomical Correlates in Korean Patients With Subcortical Vascular Cognitive Impairment

Mee Kyung Suh ,¹ Yeong Ju Cho ,¹ Byung Hwa Lee ,¹ Yisuh Ahn ²
¹ Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ²The BOM Brain Health Neuropsychology Center & Cognitive Rehabilitation Research Institute, Seoul, Korea

Dysphagia Characteristics and Its Neuroanatomical Correlates in Korean Patients With Subcortical Vascular Cognitive Impairment

Mee Kyung Suh ,¹ Yeong Ju Cho ,¹ Byung Hwa Lee ,¹ Yisuh Ahn ²
¹ Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ²The BOM Brain Health Neuropsychology Center & Cognitive Rehabilitation Research Institute, Seoul, Korea

2026; 25 103 - 114

Dysphagia; Dementia, Vascular; Time Factors; Diffusion Tensor Imaging;

Original Article

2026; 25 115 - 129/dnd-25-115.pdf 전문보기

Effects of Sarcopenia and Frailty on Cognitive Function, Brain Volume, and Dementia Risk: A Prospective Cohort Study Based on UK Biobank

Seok-Jae Heo ,¹ Min Young Chun ²,³,⁴
¹ Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea ²Department of Neurology, Yonsei University College of Medicine, Seoul, Korea ³Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, Korea ⁴Yonsei Beyond Lab, Yongin, Korea

Effects of Sarcopenia and Frailty on Cognitive Function, Brain Volume, and Dementia Risk: A Prospective Cohort Study Based on UK Biobank

Seok-Jae Heo ,¹ Min Young Chun ²,³,⁴
¹ Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea ²Department of Neurology, Yonsei University College of Medicine, Seoul, Korea ³Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, Korea ⁴Yonsei Beyond Lab, Yongin, Korea

2026; 25 115 - 129

Sarcopenia; Frailty; Cognitive Function; Brain Atrophy; Dementia;

Original Article

2026; 25 130 - 133/dnd-25-130.pdf 전문보기

Stage-Specific Efficacy of Lecanemab and Donanemab in Early Alzheimer’s Disease: An Indirect, Comparative Interpretation of Phase 3 Trials

YongSoo Shim
Department of Neurology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Stage-Specific Efficacy of Lecanemab and Donanemab in Early Alzheimer’s Disease: An Indirect, Comparative Interpretation of Phase 3 Trials

YongSoo Shim
Department of Neurology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

2026; 25 130 - 133

;

Original Article

2026; 25 134 - 136/dnd-25-134.pdf 전문보기

Demographic, Social, and Clinical Profiles of Patients Initiating Lecanemab in Clinical Practice: A Single-Center Experience in Korea

Jeongha Lee ,¹ Hyeongjin Kim ,² Hee Kyung Park ,¹,² Suah Kim ,¹ Kyung Bok Lee ,² Heekyoung Kang ,¹,² Daeun Shin ,¹,² Jun Pyo Kim ,¹,²,³ Byung Hwa Lee ¹
¹ Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ²Alzheimer’s Disease Convergence Research Center, Samsung Medical Center, Seoul, Korea ³Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Korea

Demographic, Social, and Clinical Profiles of Patients Initiating Lecanemab in Clinical Practice: A Single-Center Experience in Korea

Jeongha Lee ,¹ Hyeongjin Kim ,² Hee Kyung Park ,¹,² Suah Kim ,¹ Kyung Bok Lee ,² Heekyoung Kang ,¹,² Daeun Shin ,¹,² Jun Pyo Kim ,¹,²,³ Byung Hwa Lee ¹
¹ Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ²Alzheimer’s Disease Convergence Research Center, Samsung Medical Center, Seoul, Korea ³Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Korea

2026; 25 134 - 136

;

Original Article

2026; 25 137 - 139/dnd-25-137.pdf 전문보기

Baseline Clinical and Neuropsychological Characteristics of Amyloid PET-Confirmed Alzheimer’s Disease Treated With Lecanemab: Early Experience at a Tertiary Hospital in Korea

Hyeongjin Kim ,¹ Jeongha Lee ,² Hee Kyung Park ,¹,² Kyung Bok Lee ,¹ Jun Pyo Kim ,¹,²,³ Byung Hwa Lee ²
¹Alzheimer’s Disease Convergence Research Center, Samsung Medical Center, Seoul, Korea ² Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ³ Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Korea

Baseline Clinical and Neuropsychological Characteristics of Amyloid PET-Confirmed Alzheimer’s Disease Treated With Lecanemab: Early Experience at a Tertiary Hospital in Korea

Hyeongjin Kim ,¹ Jeongha Lee ,² Hee Kyung Park ,¹,² Kyung Bok Lee ,¹ Jun Pyo Kim ,¹,²,³ Byung Hwa Lee ²
¹Alzheimer’s Disease Convergence Research Center, Samsung Medical Center, Seoul, Korea ² Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ³ Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Korea

2026; 25 137 - 139

;

학회지